Demographics

Number = 24

Median age (range)

<40 years

≥40 years

37 years (18 - 60)

13 (54.17%)

11 (45.83%)

Pregnancy status

Median

<4

≥4

5

7 (29.16%)

17 (70.84%)

Antecedent pregnancy

Hydatidiform mole

Abortion

Term pregnancy

18 (75.00%)

4 (16.67%)

2 (8.33%)

Interval

<6 months

7 - 12 months

>12 months

Unknown

14 (58.20%)

2 (8.33%)

5 (20.83%)

3 (12.50%)

Pre-treatment HCG level

<1000

1000 - <10,000

10,000 - <100,000

≥100,000

6 (25.00%)

4 (16.67%)

7 (29.17%)

7 (29.10%)

Clinico-pathologic type

Persistent/invasive GTN

Choriocarcinoma

5 (20.83%)

19 (79.17%)

Tumor size

<4 centimeters (cm)

>5 centimeters (cm)

Unknown

8 (33.33%)

8 (33.33%)

8 (33.33%)

FIGO stage

I

II

III

IV

4 (16.60%)

7 (29.17%)

5 (20.83%)

8 (33.33%)

Radiation therapy

No

24 (100%)

Surgery

Uterine evacuation

Hysterectomy

Metastasectomy

22 (91.66%)

2 (8.33%)

0 (0.00%)

Chemotherapy

Single agent Methotrexate

Combination chemotherapy

No chemotherapy

10 (41.66%)

9 (37.50%)

5 (20.83%)